"Ross will be a tremendous addition to our team as we continue to seek out visionary early-stage companies.” John Balen, general partner at Canaan Partners
Menlo Park, California (PRWEB) November 13, 2012
Canaan Partners, a leading global venture capital firm, today announced that Ross Fubini will join the firm as venture partner. Fubini has over 15 years experience as a founder, technology executive, investor and startup advisor and will play an integral role in identifying and backing early-stage technology deals at Canaan.
“Ross is a real star in the startup community and has a strong network across seed and early-stage companies,” said John Balen, general partner at Canaan Partners. “Canaan has a long history of identifying extraordinary entrepreneurs with great ideas and then working to build these companies into durable companies. Ross will be a tremendous addition to our team as we continue to seek out visionary early-stage companies.”
“This is an exciting time to join Canaan Partners,” said Fubini. “I made the jump from a seed-stage firm to Canaan because it not your typical, large Silicon Valley VC firm. The nimble and collaborative team at Canaan understands the importance of investing in early-stage companies and supporting them for the long haul, and I look forward to helping identify the next global leaders in consumer, enterprise and healthcare IT.”
Canaan successfully raised its ninth fund, Canaan Partners IX, with $600 million in funding in January 2012 and is actively investing in digital media, consumer Internet, enterprise, mobile, biopharmaceuticals and healthcare infrastructure companies. The firm has recently funded companies such as UrbanSitter, The RealReal, borro, Instacart, adverCar and CytomX Therapeutics.
Prior to joining Canaan, Fubini was a partner at seed-stage technology investment firm Kapor Capital, where he led investments in Piazza, CitrusLane, GingerIO, KarmaLoop, ElationEMR, Omada Health and HealthLoop. At Kapor, Fubini was known for identifying passionate entrepreneurs, then working with them to build product-driven companies with global market opportunities. He has also served as an advisor to several high-growth technology companies, including Palantir Technologies, now a large private company valued at nearly $4 billion, and Facebook Causes.
“We brought Ross in as an early advisor because he is a skilled serial operator who can actually develop senior talent and work through challenges from ideas to execution, said Shyam Sankar, director of forward deployed engineering at Palantir Technologies. “He instantly understood our core vision and offered insights, strategic guidance and access to his network to help Palantir scale to what it is today."
Previously, Ross was a successful entrepreneur who co-founded and grew CubeTree, an enterprise social collaboration company, which was acquired by SuccessFactors in 2010 and where he then served as a vice president. Ross also was a senior director of engineering at Symantec, where he was in charge of product development for anti-spam, anti-virus and content filtering product lines serving 70,000 customers and delivering $300M+ in annual revenue. Before Symantec, Fubini held technical leadership roles at BEA/Plumtree, TellMe Networks and Netscape. He holds a B.S. in engineering and art minor from Carnegie Mellon University.
About Canaan Partners
Canaan Partners invests in entrepreneurs and works alongside them to turn visionary ideas into valuable companies. Since 1987, the firm has catalyzed the growth of disruptive technology startups and healthcare companies revolutionizing the practice of medicine. With $3.4 billion under management and more than 91 acquisitions and 54 IPOs to date, Canaan has funded companies such as Acme Packet, Associated Content (acquired by Yahoo), CommerceOne, DoubleClick (acquired by Google), ID Analytics (acquired by LifeLock), Match.com (acquired by IAC), SandForce (acquired by LSI) and SuccessFactors (acquired by SAP), as well as notable healthcare companies such as Advanced BioHealing (acquired by Shire), BiPar Sciences (acquired by Sanofi) and Elevation Pharmaceuticals (acquired by Sunovion). Current technology investments include Blurb, Kabam, Lending Club, Performance Marketing Brands, SOASTA, Tremor Video and Zoosk in the U.S.; BharatMatrimony and UnitedLex in India; and PrimeSense and LiveU in Israel. The Canaan healthcare portfolio includes emerging leaders such as Liquidia Technologies, Civitas Therapeutics and DICOM Grid. Canaan maintains a presence in the global innovation hubs of Silicon Valley, New York City, India and Israel. For more information visit http://www.canaan.com or http://www.facebook.com/canaanpartners.